Education
About Us
Working with TipRanks
Follow Us
Kura Oncology (DE:KUR)
FRANKFURT:KUR
Kura Oncology (KUR) Ownership Overview
1.47% Insiders
11.16%
Mutual Funds
1.70% Other Institutional Investors
14.75% ETFs
70.92% Public Companies and
Individual Investors
The ownership structure of Kura Oncology (DE:KUR) stock is a mix of institutional, retail, and individual investors. Approximately 27.61% of the company’s stock is owned by Institutional Investors, 1.47% is owned by Insiders, and 70.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 28, 2025 | Mollie Leoni Cmo | xxxxxxxxxxxxx | $39059 |
| Jan 28, 2025 | Thomas James Doyle Svp, Finance & Accounting | xxxxxxxxxxxxx | $38949 |
| Jan 28, 2025 | xxxxxxxxxxxxx | $57301 | |
| Jan 28, 2025 | xxxxxxxxxxxxx | $12458 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $443765 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $666602 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1504251 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $38768567 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,411,571 | Institution | 6.70% | 41,798,974 | |
| 4,529,134 | Institution | 5.61% | 34,983,031 | |
| 4,451,041 | Institution | 5.51% | 34,379,841 | |
| 3,976,639 | Institution | 4.92% | 30,715,560 | |
| 3,433,905 | Institution | 4.25% | 26,523,482 | |
| 1,642,734 | Institution | 2.03% | 12,688,477 | |
| 903,403 | Institution | 1.12% | 6,977,885 | |
| 798,752 | Institution | 0.99% | 6,169,560 | |
| 764,398 | Institution | 0.95% | 5,904,210 | |
| 579,753 | Insider | 0.72% | 4,478,012 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,976,639 | Institution | 4.92% | 30,715,560 | |
| 903,403 | Institution | 1.12% | 6,977,885 | |
| 798,752 | Institution | 0.99% | 6,169,560 | |
| 764,398 | Institution | 0.95% | 5,904,210 | |
| 542,507 | Institution | 0.67% | 4,190,324 | |
| 439,585 | Institution | 0.54% | 3,395,355 | |
| 412,268 | Institution | 0.51% | 3,184,358 | |
| 285,998 | Institution | 0.35% | 2,209,049 | |
| 211,647 | Institution | 0.26% | 1,634,761 | |
| 151,425 | Institution | 0.19% | 1,169,607 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Kura Oncology (DE:KUR)?
According to the latest TipRanks data, approximately 1.70% of the company's stock is held by institutional investors, 1.47% is held by insiders, and 70.92% is held by retail investors.
What percentage of Kura Oncology (DE:KUR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.70% of Kura Oncology (DE:KUR) stock is held by institutional investors.
What percentage of Kura Oncology (DE:KUR) stock is held by retail investors?
According to the latest TipRanks data, approximately 70.92% of Kura Oncology (DE:KUR) stock is held by retail investors.
Who owns the most shares of Kura Oncology (DE:KUR)?
James E. Flynn owns the most shares of Kura Oncology (DE:KUR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.